IDNA Stock: iShares Genomics Immunology and Healthcare ETF Stock Price, Analysis & Insights
Get live idna stock price $26.17, comprehensive iShares Genomics Immunology and Healthcare ETF stock analysis, charts, news, and expert forecast. Real-time idna stock data and investment insights.
Loading chart...
Company Overview
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Financial Services sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 20.9)
✓ Higher growth potential with elevated volatility (Beta: 1.42)
Business Model & Strategy
iShares Genomics Immunology and Healthcare ETF operates in the Asset Management industry, focusing on financial intermediation, banking services, and investment management. The company the company navigates Financial Services sector dynamics while pursuing growth opportunities. The Asset Management model requires risk management, regulatory compliance, and customer trust to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
iShares Genomics Immunology and Healthcare ETF competes in the Asset Management within the broader Financial Services. With 132.4 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Financial Services is characterized by economic cycles, regulatory evolution, and digital transformation. As a publicly traded company on the New York Stock Exchange Arca, iShares Genomics Immunology and Healthcare ETF provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating iShares Genomics Immunology and Healthcare ETF should consider industry-specific trends, competitive positioning, and Financial Services sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for iShares Genomics Immunology and Healthcare ETF shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Financial Services may affect company performance
- ⚠Past performance does not guarantee future results for iShares Genomics Immunology and Healthcare ETF
- ⚠Investors should consider how iShares Genomics Immunology and Healthcare ETF fits within their overall portfolio allocation
Market Cap
132.43M
P/E Ratio
20.85
Beta
1.42
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Financial Services leader with 132.43M market capitalization
- Trading Volume: 1.94K shares traded today
- Price Range: 52-week range of $17.26 - $27.65
- Exchange: Listed on New York Stock Exchange Arca
Financial Metrics
Market Analysis for iShares Genomics Immunology and Healthcare ETF
iShares Genomics Immunology and Healthcare ETF (IDNA) operates in the Asset Management industry within the Financial Services sector. With a current market capitalization of 132.43M, the company represents a significant player in its market. The stock is currently trading at $26.17 with a positivedaily change of 0.23%.
The company's substantial employee base and presence on the New York Stock Exchange Arcaexchange position it as a Financial Services sector leader. Investors should consider the stock's P/E ratio of 20.85, beta of 1.42, and 52-week price range from $17.26 to $27.65when evaluating investment opportunities.
Why Invest in iShares Genomics Immunology and Healthcare ETF?
Strengths
- • Established market presence in Financial Services
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange Arca)
- • Experienced leadership under
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Financial Services Stocks
About Financial Services Sector
The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.